Evaluation of the potential of gastric ulceration after administration of certain drugs.
D000588:Amines / Q000009:adverse effects; D000632:Aminopyrine / Q000009:adverse effects; D000818:Animals; D001205:Ascorbic Acid / Q000009:adverse effects; D001241:Aspirin / Q000009:adverse effects; D002746:Chlorpromazine / Q000009:adverse effects; D003348:Cortisone / Q000009:adverse effects; D003900:Desoxycorticosterone / Q000009:adverse effects; D004155:Diphenhydramine / Q000009:adverse effects; D005260:Female; D007213:Indomethacin / Q000009:adverse effects; D008297:Male; D010653:Phenylbutazone / Q000009:adverse effects; D011241:Prednisone / Q000009:adverse effects; D011343:Procaine / Q000009:adverse effects; D000644:Quaternary Ammonium Compounds / Q000009:adverse effects; D051381:Rats; D012110:Reserpine / Q000009:adverse effects; D013276:Stomach Ulcer / Q000139:chemically induced* / Q000473:pathology*; D013748:Tetracaine / Q000009:adverse effects
D000588:Amines; D000644:Quaternary Ammonium Compounds; D000632:Aminopyrine; D013748:Tetracaine; D003900:Desoxycorticosterone; D011343:Procaine; D012110:Reserpine; D004155:Diphenhydramine; D010653:Phenylbutazone; D001205:Ascorbic Acid; D001241:Aspirin; D002746:Chlorpromazine; D003348:Cortisone; D011241:Prednisone; D007213:Indomethacin